AAAAAA

   
Results: 1-10 |
Results: 10
PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS
Authors: MARINO MR LANGENBACHER KM RAYMOND RH FORD NF LASSETER KC
Citation: Mr. Marino et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS, Journal of clinical pharmacology, 38(4), 1998, pp. 347-356
EFFECT OF FOOD ON THE BIOAVAILABILITY OF STAVUDINE IN SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: KAUL S CHRISTOFALO B RAYMOND RH STEWART MB MACLEOD CM
Citation: S. Kaul et al., EFFECT OF FOOD ON THE BIOAVAILABILITY OF STAVUDINE IN SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2295-2298
EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II BLOCKER IRBESARTAN
Authors: MARINO MR LANGENBACHER KM FORD NE BEIERLE F RAYMOND RH SHAMBLEN EC LASSETER KC
Citation: Mr. Marino et al., EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II BLOCKER IRBESARTAN, Clinical drug investigation, 14(5), 1997, pp. 383-391
LACK OF EFFECT OF RACE ON THE PHARMACOKINETICS OF IRBESARTAN
Authors: VACHHARAJANI NN SHYU WC RAYMOND RH REEVES RA GREENE DS BARBHAIYA RH
Citation: Nn. Vachharajani et al., LACK OF EFFECT OF RACE ON THE PHARMACOKINETICS OF IRBESARTAN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 91-91
PHARMACOKINETIC (PK) MODELING OF BMS-188667 (CTLA4IG)
Authors: SONNICHSEN DS SUMMERILL RS RAYMOND RH WEINER RS ABRAMS JR BIRKHOFER MJ
Citation: Ds. Sonnichsen et al., PHARMACOKINETIC (PK) MODELING OF BMS-188667 (CTLA4IG), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 104-104
SINGLE BOLUS REGIMEN OF LANOTEPLASE (NPA) IN ACUTE MYOCARDIAL-INFARCTION - PHARMACOKINETIC EVALUATION FROM IN TIME-I STUDY
Authors: LIAO WC BEIERLE FA STOUFFER BC DOCKENS RC ABBUD ZA TAY LK KNAUS DM RAYMOND RH CHEW PH KOSTIS JB
Citation: Wc. Liao et al., SINGLE BOLUS REGIMEN OF LANOTEPLASE (NPA) IN ACUTE MYOCARDIAL-INFARCTION - PHARMACOKINETIC EVALUATION FROM IN TIME-I STUDY, Circulation, 96(8), 1997, pp. 1446-1446
PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF WARFARIN AND NEFAZODONE COADMINISTRATION IN HEALTHY-SUBJECTS
Authors: SALAZAR DE DOCKENS RC MILBRATH RL RAYMOND RH FULMOR IE CHAIKIN PC UDERMAN HD
Citation: De. Salazar et al., PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF WARFARIN AND NEFAZODONE COADMINISTRATION IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 35(7), 1995, pp. 730-738
PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION DURING COADMINISTRATION OF NEFAZODONE AND PROPRANOLOL IN HEALTHY-MEN
Authors: SALAZAR DE MARATHE PH FULMOR IE LEE JS RAYMOND RH UDERMAN HD
Citation: De. Salazar et al., PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION DURING COADMINISTRATION OF NEFAZODONE AND PROPRANOLOL IN HEALTHY-MEN, Journal of clinical pharmacology, 35(11), 1995, pp. 1109-1118
THE EFFECTS OF NEFAZODONE AND FLUOXETINE ON PLATELET SEROTONIN UPTAKEAND WHOLE-BLOOD SEROTONIN
Authors: SALAZAR DE CHAIKIN PC SWANSON BN RAYMOND RH
Citation: De. Salazar et al., THE EFFECTS OF NEFAZODONE AND FLUOXETINE ON PLATELET SEROTONIN UPTAKEAND WHOLE-BLOOD SEROTONIN, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 137-137
SIMULTANEOUS MODELING OF PHARMACOKINETICS AND PHARMACODYNAMICS IN THEESTIMATION OF THE EFFECT OF D-SOTALOL ON QTC INTERVAL
Authors: RAYMOND RH SLUGG P MUCH DR
Citation: Rh. Raymond et al., SIMULTANEOUS MODELING OF PHARMACOKINETICS AND PHARMACODYNAMICS IN THEESTIMATION OF THE EFFECT OF D-SOTALOL ON QTC INTERVAL, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 147-147
Risultati: 1-10 |